BIOX Intrinsic Value – BIOCERES CROP SOLUTIONS Reports Q2 FY2023 Earnings Results on February 28, 2023.
March 10, 2023
Earnings Overview
BIOCERES CROP SOLUTIONS ($NASDAQ:BIOX) reported a decrease in total revenue of 337.9% for the second quarter of the 2023 financial year (ending December 31 2022), amounting to USD -8.2 million, on February 28 2023. Despite this, net income was up by 2.4% year over year, at USD 94.5 million.
Transcripts Simplified
Bioceris Crop Solutions is proud to present the results of its HB4 Wheat technology, which helps to improve yields significantly in environments with yields below two tons per hectare. Results have been observed in hundreds of grower fields and thousands of hectares in multiple seasons, showing an improvement of over 40%. Even when accounting for genetic background noise, the HB4 wheat converted lines have won in all environments, not just those with yields below two tonnes per hectare.
This year, the technology is expected to deliver between $15 million to $20 million in enterable EBITDA. The company’s ambition is to bring HB4 Wheat to farmers everywhere in the world where wheat is relevant and droughts are prevalent, starting with Australia.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for BIOX. More…
| Total Revenues | Net Income | Net Margin |
| 391.18 | -19.16 | -3.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for BIOX. More…
| Operations | Investing | Financing |
| 11.18 | -20.28 | 37.39 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for BIOX. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 872.85 | 566.23 | 4.43 |
Key Ratios Snapshot
Some of the financial key ratios for BIOX are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 27.0% | 9.1% | 5.4% |
| FCF Margin | ROE | ROA |
| -0.8% | 4.8% | 1.5% |
Stock Price
On Tuesday, BIOCERES CROP SOLUTIONS reported its Q2 FY2023 earnings results for the period ending February 28, 2023. The company’s stock opened at $11.6 and closed at $11.5, up by 0.6% from its prior closing price of 11.5. Overall, BIOCERES CROP SOLUTIONS reported strong financial results for the period ending February 28, 2023, indicating a positive trend for the company.
The company’s stock has increased slightly since the same period last year and its adjusted EPS was higher than expected. As a result, investors are likely to remain optimistic about the future prospects of BIOCERES CROP SOLUTIONS. Live Quote…
Analysis – BIOX Intrinsic Value
At GoodWhale, we ran an analysis of the financials of BIOCERES CROP SOLUTIONS. After crunching the numbers, our proprietary Valuation Line showed the intrinsic value of BIOCERES CROP SOLUTIONS share to be around $11.5. This means that BIOCERES CROP SOLUTIONS stock is currently trading at a fair price. More…
Peers
In the world of agriculture, there are many companies vying for supremacy. Two of the most prominent companies in this arena are Bioceres Crop Solutions Corp and its competitor, Argo Living Soils Corp. Both of these companies have developed innovative products and services that have revolutionized the way farmers grow crops. While Bioceres has a slight edge in terms of market share, Argo is not far behind and is constantly innovating in order to catch up. The competition between these two companies is fierce, and it is benefiting farmers all over the world.
– Argo Living Soils Corp ($OTCPK:ARLSF)
Argo Living Soils Corp is a Canadian company that specializes in the production of organic soils and amendments. The company’s products are used by commercial growers, farmers, and home gardeners. Argo Living Soils Corp has a market cap of 1.61M as of 2022. The company’s return on equity is 83.33%.
– EarthRenew Inc ($OTCPK:VVIVF)
The company’s market cap is 13.41M as of 2022. The company’s ROE is -24.3%. The company focuses on providing renewable energy solutions to businesses and homeowners. The company operates in three segments: Solar, Wind, and Other. The Solar segment provides solar power systems for residential and commercial customers. The Wind segment provides wind turbines for residential and commercial customers. The Other segment provides energy storage solutions and energy efficiency products.
– Kiwa Bio-Tech Products Group Corp ($OTCPK:KWBT)
Kiwa Bio-Tech Products Group Corp is a China-based company that engages in the research, development, manufacture, and sale of bio-pesticides and bio-fertilizers. The company has a market cap of 56.48k as of 2022 and a Return on Equity of -5.54%. Kiwa Bio-Tech Products Group Corp is a leading player in the bio-pesticides and bio-fertilizers industry in China. The company’s products are sold to over 30 provinces and municipalities in China, and are exported to over 50 countries and regions worldwide.
Summary
Biocerres Crop Solutions has reported a Q2 2023 financial performance that was a stark contrast to the same period of the previous year. Total revenue decreased 337.9%, however, net income was up 2.4%. This suggests that investors should consider the company’s long-term potential and its current financial situation when evaluating potential investments.
It is also important to consider the risks associated with any potential investments, such as market trends, competition, and regulatory changes. Ultimately, investors should use their own judgment when considering Biocerres Crop Solutions as an investment option.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
